Insider Selling: Jason Zellers Unloads 14,917 Shares of St. Jude Medical Stock (STJ)
St. Jude Medical (NYSE:STJ) VP Jason Zellers unloaded 14,917 shares of the company’s stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $57.15, for a total transaction of $852,506.55. Following the completion of the sale, the vice president now directly owns 1,686 shares in the company, valued at approximately $96,355. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
STJ has been the subject of a number of recent research reports. Analysts at RBC Capital raised their price target on shares of St. Jude Medical from $40.00 to $44.00 in a research note to investors on Thursday, October 17th. They now have an “underperform” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of St. Jude Medical in a research note to investors on Thursday, October 17th. They now have a $59.00 price target on the stock. Finally, analysts at Credit Suisse raised their price target on shares of St. Jude Medical from $55.00 to $60.00 in a research note to investors on Thursday, October 17th. They now have an “outperform” rating on the stock. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $49.80.
St. Jude Medical (NYSE:STJ) traded up 1.38% on Friday, hitting $57.27. The stock had a trading volume of 1,914,204 shares. St. Jude Medical has a 1-year low of $30.25 and a 1-year high of $54.06. The stock has a 50-day moving average of $52.21 and a 200-day moving average of $46.01. The company has a market cap of $16.723 billion and a P/E ratio of 23.07.
St. Jude Medical (NYSE:STJ) last released its earnings data on Wednesday, October 16th. The company reported $0.90 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.89 by $0.01. The company had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.32 billion. During the same quarter in the prior year, the company posted $0.83 earnings per share. The company’s quarterly revenue was up .9% on a year-over-year basis.
St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.